NO143381C - Analogifremgangsmaate ved fremstilling av farmakologisk aktive guanidin- og isotioureaderivater - Google Patents
Analogifremgangsmaate ved fremstilling av farmakologisk aktive guanidin- og isotioureaderivaterInfo
- Publication number
- NO143381C NO143381C NO750809A NO750809A NO143381C NO 143381 C NO143381 C NO 143381C NO 750809 A NO750809 A NO 750809A NO 750809 A NO750809 A NO 750809A NO 143381 C NO143381 C NO 143381C
- Authority
- NO
- Norway
- Prior art keywords
- isotioure
- addes
- preparation
- pharmacologically active
- analogue procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB10869/74A GB1496787A (en) | 1974-03-12 | 1974-03-12 | Heteroalkylthioalkyl amidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO750809L NO750809L (no) | 1975-09-15 |
| NO143381B NO143381B (no) | 1980-10-20 |
| NO143381C true NO143381C (no) | 1981-01-28 |
Family
ID=9975816
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO750809A NO143381C (no) | 1974-03-12 | 1975-03-11 | Analogifremgangsmaate ved fremstilling av farmakologisk aktive guanidin- og isotioureaderivater |
| NO794346A NO794346L (no) | 1974-03-12 | 1979-12-28 | Fremgangsmaate for fremstilling av farmakologisk aktive forbindelser |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO794346A NO794346L (no) | 1974-03-12 | 1979-12-28 | Fremgangsmaate for fremstilling av farmakologisk aktive forbindelser |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US4036971A (no) |
| JP (1) | JPS5946220B2 (no) |
| BE (1) | BE825976A (no) |
| CA (1) | CA1055505A (no) |
| DE (1) | DE2510860A1 (no) |
| DK (1) | DK74675A (no) |
| ES (1) | ES435540A1 (no) |
| FR (1) | FR2263765B1 (no) |
| GB (1) | GB1496787A (no) |
| HU (1) | HU171049B (no) |
| IE (1) | IE40725B1 (no) |
| IL (1) | IL46638A0 (no) |
| LU (1) | LU72013A1 (no) |
| NL (1) | NL7502935A (no) |
| NO (2) | NO143381C (no) |
| PH (1) | PH14072A (no) |
| PL (1) | PL100317B1 (no) |
| SE (1) | SE7502715L (no) |
| ZA (1) | ZA75870B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1496787A (en) * | 1974-03-12 | 1978-01-05 | Smith Kline French Lab | Heteroalkylthioalkyl amidine derivatives |
| NZ186965A (en) | 1977-04-20 | 1980-02-21 | Ici Ltd | Guanidino derivatives and pharmaceutical compositions |
| US4165378A (en) | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
| IL57415A (en) * | 1978-05-30 | 1984-08-31 | Smith Kline French Lab | Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them |
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| US4262125A (en) * | 1979-07-23 | 1981-04-14 | American Home Products Corporation | (1H-Imidazol-5-ylmethyl)isothioureas |
| US4382090A (en) * | 1980-10-02 | 1983-05-03 | Eli Lilly And Company | N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds |
| IE53068B1 (en) * | 1981-06-15 | 1988-05-25 | Merck & Co Inc | Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors |
| JP3003148B2 (ja) * | 1989-01-05 | 2000-01-24 | 藤沢薬品工業株式会社 | チアゾール化合物、その製造法およびそれを含有する医薬組成物 |
| FR2883257B1 (fr) * | 2005-03-18 | 2007-06-01 | Thales Sa | Dispositif de compensation de jeu mecanique de commande de vol d'helicoptere |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3868457A (en) * | 1969-10-29 | 1975-02-25 | Smith Kline French Lab | Method of inhibiting histamine activity with guanidine compounds |
| BE758146A (fr) * | 1969-10-29 | 1971-04-28 | Smith Kline French Lab | Derives de l'amidine |
| US3734924A (en) * | 1970-10-14 | 1973-05-22 | Smith Kline French Lab | Carboxamidines |
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| US3979398A (en) * | 1973-02-08 | 1976-09-07 | Smith Kline & French Laboratories Limited | Sulphoxides |
| US4025527A (en) * | 1973-07-13 | 1977-05-24 | Smith Kline & French Laboratories Limited | Certain thiazoles and oxazoles |
| US4118496A (en) * | 1974-03-12 | 1978-10-03 | Smith Kline & French Laboratories Limited | Heterocyclic-methylthioalkyl-amidines |
| GB1496787A (en) * | 1974-03-12 | 1978-01-05 | Smith Kline French Lab | Heteroalkylthioalkyl amidine derivatives |
| GB1497260A (en) * | 1974-06-28 | 1978-01-05 | Smith Kline French Lab | Guanidine derivatives |
| GB1531231A (en) * | 1974-09-02 | 1978-11-08 | Smith Kline French Lab | Process for the production of cyanoguanidine derivatives |
| US4120966A (en) * | 1975-02-03 | 1978-10-17 | Smith Kline & French Laboratories Limited | Heterocyclic-methylthioethyl-dithiocarbamates and isothioureas |
-
1974
- 1974-03-12 GB GB10869/74A patent/GB1496787A/en not_active Expired
-
1975
- 1975-02-11 ZA ZA00750870A patent/ZA75870B/xx unknown
- 1975-02-14 CA CA220,151A patent/CA1055505A/en not_active Expired
- 1975-02-14 IL IL46638A patent/IL46638A0/xx unknown
- 1975-02-19 IE IE340/75A patent/IE40725B1/xx unknown
- 1975-02-19 US US05/551,220 patent/US4036971A/en not_active Expired - Lifetime
- 1975-02-26 BE BE153733A patent/BE825976A/xx not_active IP Right Cessation
- 1975-02-26 DK DK74675*#A patent/DK74675A/da unknown
- 1975-03-04 FR FR7506687A patent/FR2263765B1/fr not_active Expired
- 1975-03-07 JP JP50028592A patent/JPS5946220B2/ja not_active Expired
- 1975-03-07 PH PH16881A patent/PH14072A/en unknown
- 1975-03-10 LU LU72013A patent/LU72013A1/xx unknown
- 1975-03-11 NO NO750809A patent/NO143381C/no unknown
- 1975-03-11 PL PL1975178679A patent/PL100317B1/pl unknown
- 1975-03-11 SE SE7502715A patent/SE7502715L/xx unknown
- 1975-03-12 ES ES435540A patent/ES435540A1/es not_active Expired
- 1975-03-12 HU HU75SI00001458A patent/HU171049B/hu unknown
- 1975-03-12 NL NL7502935A patent/NL7502935A/xx not_active Application Discontinuation
- 1975-03-12 DE DE19752510860 patent/DE2510860A1/de not_active Ceased
-
1979
- 1979-05-14 US US06/039,090 patent/US4282234A/en not_active Expired - Lifetime
- 1979-12-28 NO NO794346A patent/NO794346L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES435540A1 (es) | 1976-12-16 |
| BE825976A (fr) | 1975-08-26 |
| IL46638A0 (en) | 1975-04-25 |
| US4282234A (en) | 1981-08-04 |
| GB1496787A (en) | 1978-01-05 |
| IE40725L (en) | 1975-09-12 |
| US4036971A (en) | 1977-07-19 |
| NO750809L (no) | 1975-09-15 |
| AU7831175A (en) | 1976-08-19 |
| NO794346L (no) | 1975-09-15 |
| LU72013A1 (no) | 1975-08-20 |
| SE7502715L (no) | 1975-09-15 |
| FR2263765B1 (no) | 1978-08-04 |
| PL100317B1 (pl) | 1978-09-30 |
| JPS5946220B2 (ja) | 1984-11-10 |
| ZA75870B (en) | 1976-01-28 |
| NL7502935A (nl) | 1975-09-16 |
| NO143381B (no) | 1980-10-20 |
| PH14072A (en) | 1981-01-26 |
| DE2510860A1 (de) | 1975-09-18 |
| FR2263765A1 (no) | 1975-10-10 |
| DK74675A (no) | 1975-09-13 |
| HU171049B (hu) | 1977-10-28 |
| IE40725B1 (en) | 1979-08-01 |
| CA1055505A (en) | 1979-05-29 |
| JPS50129550A (no) | 1975-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO141163C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidiner | |
| NO149106C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider | |
| NO142034C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere. | |
| NO157933C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser. | |
| NO145382C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater. | |
| NO141013C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater | |
| NO141717C (no) | Analogifremgangsmaate til fremstilling av farmakologisk aktive triazolopyridaziner | |
| NO146865C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater | |
| NO143381C (no) | Analogifremgangsmaate ved fremstilling av farmakologisk aktive guanidin- og isotioureaderivater | |
| NO144670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-substituerte-3-pyrrolidinyl)-1-nafthalen- og 4-kinolincarboxamider | |
| SE7506947L (sv) | Farmakologiskt aktiva foreningar | |
| NO141472C (no) | Fremgangsmaate for fremstilling av polysakkarider og derivater derav | |
| NO141894C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner | |
| NO143459C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive 2-fenylimino-imidazolidin-derivater | |
| AR212858A1 (es) | Procedimiento para la preparacion de derivados farmaceuticamente activos fenipolieno carboxilicos | |
| NO140824C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener | |
| NO810816L (no) | Utgangsmateriale for fremstilling av terapeutisk aktive aminosyrederivater | |
| NO144108C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider | |
| NO144928C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater. | |
| NO143317C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder | |
| NO145950C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider | |
| SE431204B (sv) | Forfarande for framstellning av n?722-naftalensulfonyl-l-argininestrar och -amider eller farmaceutiskt accepterbara syraadditionssalter derav | |
| NO137894C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer | |
| NO143499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater | |
| NO145383C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler. |